Polaris Market Research today announced findings from its latest report, projecting the global Cardiac Monitoring and Cardiac Rhythm Management Devices market to grow from USD 21.76 billion in 2024 to USD 34.90 billion by 2034, at a CAGR of 4.85% from 2025 to 2034. The report profiles 12 leading companies across four core market segments, offering a detailed view of market size, competitive positioning, and regional demand patterns. The market, valued at USD 22.78 billion in 2025, covers pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices, wearables, and remote monitoring systems used to diagnose, monitor, and treat cardiovascular disease with growing precision.

Analyst Commentary on Cardiac Monitoring and Cardiac Rhythm Management Devices Market Growth

"The rising global burden of cardiovascular disease, coupled with a rapidly aging population, is accelerating market growth for implantable and wearable cardiac devices," said a Senior Analyst at Polaris Market Research. "Buyers and investors evaluating market entry will find the strongest near-term opportunity in AI-enabled remote monitoring and minimally invasive rhythm-management technologies."

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Statistics at a Glance

• 2024 Market Size: USD 21.76 Billion
• 2034 Projected Size: USD 34.90 Billion
• CAGR (2025–2034): 4.85%
• Largest Region (2024): North America

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: the rising global burden of cardiovascular disease, growing aging populations in developed and emerging economies, and rapid advancements in miniaturized implants, wireless connectivity, and AI-enabled monitoring are the primary forces behind the market's expansion, alongside growing demand for remote patient monitoring systems. According to the World Health Organization, cardiovascular diseases cause 17.9 million deaths annually, with more than 80% linked to heart attacks and strokes, underscoring the urgency of early intervention through pacemakers, ICDs, and wearable monitors. In April 2025, HeartBeam partnered with AccurKardia to integrate FDA-cleared AccurECG software onto its handheld ECG device, extending cardiac monitoring beyond conventional care settings. The world's population aged 60 and above is projected to rise from 1 billion in 2020 to 2.1 billion by 2050, further reinforcing long-term demand for continuous cardiac monitoring and stabilization therapies.

Major Companies Covered: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE HealthCare Technologies Inc., and Koninklijke Philips N.V., alongside other notable participants such as Biotronik SE & Co. KG, Nihon Kohden Corporation, and AliveCor Inc., which continue to invest in device accuracy, patient safety, and comfort.

Segments Covered: By Type (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), By Procedure (Invasive, Non-invasive), By End User, By Region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/cardiac-monitoring-and-cardiac-rhythm-management-devices-market 

Recent Developments in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market

• August 2025: Cardiosense's CardioTag wearable heart monitor received FDA clearance, becoming the first device to capture ECG, PPG, and SCG signals together for AI-driven heart failure management.
• March 2025: MicroPort CRM received CE Mark approval for its SmartView Connect App on Android, enabling Bluetooth pacemakers, ICDs, and CRT-D devices to transmit data securely without a bedside monitor.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led the market in 2024, supported by a high prevalence of cardiovascular disease, sophisticated healthcare infrastructure, and strong reimbursement policies favoring advanced implantable devices, with the U.S. accounting for the largest regional share on the strength of robust R&D, FDA-approved devices, and expanding telemedicine integration. Asia Pacific, meanwhile, is projected to register the fastest CAGR through 2034 on the back of rising healthcare expenditure, expanding hospital infrastructure, and growing awareness of early cardiac detection across China, Japan, and India, with China's large elderly patient base and government health programs further accelerating regional adoption.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching top companies and market forecasts in cardiac care, the underlying report benchmarks Cardiac Monitoring and Cardiac Rhythm Management Devices market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034. The cardiac monitoring devices segment led the market in 2024 on strong adoption of wearable ECGs and Holter monitors, while cardiac rhythm management devices are expected to post the fastest segment CAGR as pacemakers, ICDs, and CRT devices see growing uptake across ambulatory surgery centers.

More Trending Latest Reports By Polaris Market Research:

Green Food Supplements Market

Thermoform Packaging Market

Phenolic Resin Market

Protein A, G, and L Resins Market

Thermoform Packaging Market

Agricultural Robots Market

Wafer Vacuum Assembling Equipment Market

Unleashing the Potential of the Wood Pellet Market

Europe Antibody Specificity Testing Market